Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Polyketide macrolides produced by mycobacteria exert anticancer, antiinflammatory effects

Feb. 5, 2001

IMC-C225 granted fast track designation for refractory colorectal carcinoma

Feb. 5, 2001

CoPharma licenses anticancer compound from Dana-Farber

Feb. 5, 2001

EMEA begins review of Trisenox for APL indication

Feb. 5, 2001

Split-dose schedule of RPR-109881A explored in phase I trial in Canada

Feb. 5, 2001

Thiophene integrin inhibitors designed at BioChem Pharma

Feb. 2, 2001

Theratechnologies' ex vivo PDT cell therapy system enters clinical testing

Feb. 2, 2001

SafeScience gains additional patent rights to GBC-590

Feb. 2, 2001

YM BioSciences and SR Pharma to codevelop cancer vaccine

Feb. 2, 2001

Novogen phase I trial of anticancer drug phenoxodiol approved by FDA

Feb. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...